A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B [1]

British Journal of Haematology

Volumn 128, Issue 6, 2005, Pages 885-

  Keeling, David ^a   Beavis, James ^a   Sukhu, Kampta ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Bethesda assay; Haemophilia; Inhibitor screen

Indexed keywords

BLOOD CLOTTING FACTOR 9; RITUXIMAB;

ANTIBODY DETECTION; ANTIBODY SCREENING; CASE REPORT; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFANT; INTERMETHOD COMPARISON; LETTER; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANTIBODIES; CHILD; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INFANT; MALE; SENSITIVITY AND SPECIFICITY;

EID: 15944372558     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05399.x     Document Type: Letter

References (3)

1. Ewing, N.P. & Kasper, C.K. (1982) In vitro detection of mild inhibitors to factor VIII in hemophilia. American Journal of Clinical Pathology, 77, 749-752.
2. Hay, C.R., Baglin, T.P., Collins, P.W., Hill, F.G. & Keeling, D.M. (2000) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). British Journal of Haematology, 111, 78-90.
3. Verbruggen, B., Novakova, I., Wessels, H., Boezeman, J., van den Berg, M. & Mauser-Bunschoten, E. (1995) The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thrombosis and Haemostasis, 73, 247-251.